Free Trial
Your $100 Credit Expires Tomorrow! Get MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Shares Cross Above 200 Day Moving Average - Time to Sell?

NorthWest Health Prop Real Est Inv Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Shares crossed above its 200-day moving average, trading as high as C$5.63 and last at C$5.60 versus the 200‑day MA of C$5.42 (50‑day MA C$5.61), on volume of 397,233 shares.
  • Analysts remain cautious: ATB Cormark cut the stock to "sector perform" (C$6.25 target) while RBC raised its target to C$6.00, leaving a consensus rating of "Hold" with a C$6.20 target.
  • Fundamentals show stress—the REIT reported C($0.16) EPS for the quarter, has a negative P/E (-26.49), a negative net margin (75.29%), and high leverage (debt-to-equity 129.42), indicating financial risk despite the technical move.
  • MarketBeat previews the top five stocks to own by June 1st.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$5.42 and traded as high as C$5.63. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.60, with a volume of 397,233 shares.

Analyst Ratings Changes

NWH.UN has been the topic of a number of analyst reports. ATB Cormark Capital Markets lowered shares of NorthWest Health Prop Real Est Inv Trust from an "outperform" rating to a "sector perform" rating and set a C$6.25 target price on the stock. in a report on Friday, February 27th. Royal Bank Of Canada upped their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$6.00 and gave the stock a "sector perform" rating in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of C$6.20.

Read Our Latest Report on NorthWest Health Prop Real Est Inv Trust

NorthWest Health Prop Real Est Inv Trust Stock Performance

The firm has a market capitalization of C$1.39 billion, a P/E ratio of -26.49, a price-to-earnings-growth ratio of 0.74 and a beta of 1.63. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The business's 50 day simple moving average is C$5.61 and its two-hundred day simple moving average is C$5.42.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) last released its quarterly earnings data on Tuesday, February 24th. The company reported C($0.16) earnings per share for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The firm had revenue of C$102.27 million for the quarter. Sell-side analysts anticipate that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current fiscal year.

NorthWest Health Prop Real Est Inv Trust Company Profile

(Get Free Report)

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NorthWest Health Prop Real Est Inv Trust Right Now?

Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.

While NorthWest Health Prop Real Est Inv Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines